IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 144 filers reported holding IMMUNOMEDICS INC in Q2 2017. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $5,392,000 | -85.4% | 400,000 | -77.1% | 8.59% | -58.6% |
| Q4 2019 | $37,030,000 | +42.7% | 1,750,000 | -10.5% | 20.75% | +109.5% |
| Q3 2019 | $25,941,000 | -3.5% | 1,956,362 | +0.9% | 9.90% | +12.3% |
| Q2 2019 | $26,889,000 | -41.8% | 1,938,612 | -19.3% | 8.82% | -26.6% |
| Q1 2019 | $46,169,000 | +19.8% | 2,403,398 | -11.0% | 12.02% | -5.0% |
| Q4 2018 | $38,529,000 | -31.3% | 2,700,000 | +0.3% | 12.65% | +2.3% |
| Q3 2018 | $56,069,000 | -6.8% | 2,691,729 | +5.9% | 12.37% | -4.5% |
| Q2 2018 | $60,163,000 | +52.5% | 2,541,729 | -5.9% | 12.96% | +50.7% |
| Q1 2018 | $39,447,000 | -9.6% | 2,700,000 | 0.0% | 8.60% | -29.8% |
| Q4 2017 | $43,632,000 | +31.2% | 2,700,000 | +13.5% | 12.24% | +33.6% |
| Q3 2017 | $33,264,000 | +94.1% | 2,379,367 | +22.6% | 9.16% | +63.7% |
| Q2 2017 | $17,138,000 | +1432.9% | 1,940,850 | +1022.7% | 5.60% | +1204.9% |
| Q1 2017 | $1,118,000 | – | 172,871 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 10,488,076 | $92,610,000 | 11.69% |
| First Light Asset Management, LLC | 2,048,643 | $18,090,000 | 6.07% |
| Foresite Capital Management III, LLC | 1,940,850 | $17,138,000 | 5.60% |
| DAFNA Capital Management LLC | 637,700 | $5,631,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 1,600,000 | $14,128,000 | 3.95% |
| Opaleye Management Inc. | 900,000 | $7,947,000 | 3.32% |
| Ghost Tree Capital, LLC | 1,200,000 | $10,596,000 | 2.20% |
| Iguana Healthcare Management, LLC | 325,000 | $2,870,000 | 1.62% |
| Healthcare Value Capital, LLC | 100,000 | $883,000 | 1.59% |
| Palo Alto Investors LP | 3,010,466 | $26,582,000 | 1.24% |